Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Medical Oncology|August 11, 2017
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerationsGino K In, James S Hu, William W Tseng
Military Medicine|October 19, 2022
Physician Burnout-Evidence That Leadership Behaviors Make a Difference: A Cross-Sectional Survey of an Academic Medical CenterJames S Hu, Jennifer Phillips, Choo Phei Wee, et al.
Journal of Healthcare Leadership|March 7, 2024
Physician Leadership and Burnout: The Need for Agency; a Qualitative Study of an Academic InstitutionJames S Hu, Louis N Pangaro, Bami M Gloria Andrada, et al.
Journal of Medical Case Reports|June 27, 2022
Tumor lysis syndrome following ifosfamide monotherapy in metastatic osteosarcoma: a case report and review of the literatureSteven N Luminais, Xiao T Chen, Darwin Roman, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|July 25, 2015
Contrast-Enhanced Sonography for Monitoring Neoadjuvant Chemotherapy in Soft Tissue SarcomasMittul Gulati, James S Hu, Bhushan Desai, et al.
Current Oncology Reports|June 21, 2015
Contemporary Management of Retroperitoneal Soft Tissue SarcomasYuliya Olimpiadi, Suisui Song, James S Hu, et al.
Acta Neurochirurgica|August 12, 2020
Predictors of readmission after craniotomy for meningioma resection: a nationwide readmission database analysisMichelle Lin, Elliot Min, Elliott A Orloff, et al.
Cancer|August 24, 2017
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancerTanya B Dorff, Jeff A Longmate, Sumanta K Pal, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.
Pageof 2